首页> 美国卫生研究院文献>Stem Cell Research Therapy >Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury
【2h】

Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury

机译:人和小鼠脂肪干细胞在脂多糖诱导的急性肺损伤小鼠模型中的治疗效果比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionAdipose-derived stem cells (ASCs) have emerged as important regulators of inflammatory/immune responses in vitro and in vivo and represent attractive candidates for cell-based therapies for diseases that involve excessive inflammation. Acute lung injury (ALI) is an inflammatory condition for which treatment is mainly supportive due to lack of effective therapies. In this study, the therapeutic effects of ASC-based therapy were assessed in vivo by comparison of the anti-inflammatory properties of both human and murine ASCs in a mouse model of lipopolysaccharide (LPS)-induced ALI.
机译:简介脂肪干细胞(ASC)已成为体外和体内炎症/免疫反应的重要调节剂,并代表了针对涉及过度炎症的疾病的细胞疗法的有吸引力的候选药物。急性肺损伤(ALI)是一种炎症性疾病,由于缺乏有效的治疗方法,其治疗主要是支持性的。在这项研究中,通过在脂多糖(LPS)诱导的ALI小鼠模型中比较人和鼠ASC的抗炎特性,在体内评估了基于ASC的治疗的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号